Shortly after the Food and Drug Administration (FDA) granted approval for the Comirnaty COVID-19 vaccine, the Lynnwood Times asked the administration several clarifying questions regarding the approval and the rebranding of Pfizer’s vaccine.  Certain components of the FDA’s literature on the matter left questions unanswered. For example, why is the Pfizer-BioNTech COVID-19 Vaccine being marketed … Continue reading FDA-approved Pfizer Comirnaty vaccine clarifications